Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.5%

4 terminated out of 42 trials

Success Rate

85.2%

-1.3% vs benchmark

Late-Stage Pipeline

24%

10 trials in Phase 3/4

Results Transparency

26%

6 of 23 completed with results

Key Signals

6 with results85% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (11)
P 1 (2)
P 2 (4)
P 3 (7)
P 4 (3)

Trial Status

Completed23
Unknown7
Terminated4
Active Not Recruiting3
Recruiting3
Withdrawn1

Trial Success Rate

85.2%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT07095257Phase 3CompletedPrimary

Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza

NCT06417762Not ApplicableRecruiting

Dime La VerDAD: Verify, Debunk, and Disseminate

NCT04826991Not ApplicableActive Not Recruiting

Wells and Enteric Disease Transmission

NCT07357051Phase 3RecruitingPrimary

Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

NCT05381454Phase 1CompletedPrimary

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

NCT05550298Recruiting

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

NCT06149494Phase 2Completed

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

NCT04258059Not ApplicableCompleted

Wells and Enteric Disease Transmission Trial (WET - Trial)

NCT06669351Phase 3TerminatedPrimary

Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza

NCT05913700Active Not Recruiting

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)

NCT06841926Phase 1CompletedPrimary

Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males

NCT06247059Not ApplicableNot Yet Recruiting

Reducing Respiratory Virus Transmission in Bangladeshi Classrooms

NCT04898023Phase 2TerminatedPrimary

Zinc and Green Tea Extract for Community Respiratory Viral Infections

NCT06099873Phase 3CompletedPrimary

Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza

NCT04664075Terminated

Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)

NCT06188988Unknown

Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis

NCT04842331Phase 2WithdrawnPrimary

PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)

NCT05846360CompletedPrimary

The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer

NCT04532411Completed

COVID-19 Testing Sample Acquisition Throughput and Efficiency

NCT05544916Phase 3Completed

A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Scroll to load more

Research Network

Activity Timeline